Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Arial" (20)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Treosulfan (L01AB02) 2 products
WHO-DDD
L
IP
Trecondi 1 g
114.23
140.65
10 %
Lyophilisate: Treosulfanum 1 g
Ideogen AG
A / SL
FB
G
L
IP
Trecondi 5 g
548.76
613.25
10 %
Lyophilisate: Treosulfanum 5 g
Ideogen AG
A / SL
FB
G
Topotecan (L01CE01) 3 products
WHO-DDD
L
IP
Topotecan Accord 1 mg
68.15
90.55
10 %
Concentrate for infusion: Topotecanum 1 mg/ml
Accord Healthcare AG
●
A / SL / SG
FB
G
L
IP
Topotecan Accord 4 mg
242.89
280.55
10 %
Concentrate for infusion: Topotecanum 4mg / 4ml
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
Topotecan Accord 4 mg
5
1209.37
1331.70
10 %
Concentrate for infusion: Topotecanum 4mg / 4ml
Accord Healthcare AG
A / SL / SG
FB
G
(L01FG01) 2 products
WHO-DDD
L
IP
Oyavas 100 mg/4 ml
257.57
296.55
10 %
Concentrate for infusion: Bevacizumabum 100mg / 4ml
Spirig HealthCare AG
A / SL
FB
G
L
IP
Oyavas 400 mg/16 ml
962.84
1063.55
10 %
Concentrate for infusion: Bevacizumabum 400mg / 16ml
Spirig HealthCare AG
A / SL
FB
G
(L01FG01) 2 products
WHO-DDD
L
SIP
IP
CI
Avastin 100 mg/4 ml
Durchstechflasche(n)
283.32
322.95
10 %
Concentrate for infusion: Bevacizumabum 100mg / 4ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
SIP
IP
CI
Avastin 400 mg/16 ml
Durchstechflasche(n)
1059.11
1162.35
10 %
Concentrate for infusion: Bevacizumabum 400mg / 16ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
Rucaparib (L01XK03) 6 products
WHO-DDD
L
IP
CI
Rubraca 200 mg
60
1823.35
1999.40
10 %
Coated tablets: Rucaparibum 200 mg
mmpharm GmbH
A / SL
FB
G
L
IP
CI
Rubraca 200 mg
120
3646.70
3982.40
10 %
Coated tablets: Rucaparibum 200 mg
mmpharm GmbH
A / SL
FB
G
L
IP
Rubraca 250 mg
60
2279.19
2495.15
10 %
Coated tablets: Rucaparibum 250 mg
mmpharm GmbH
A / SL
FB
G
L
IP
Rubraca 250 mg
120
4558.38
4973.95
10 %
Coated tablets: Rucaparibum 250 mg
mmpharm GmbH
A / SL
FB
G
L
IP
Rubraca 300 mg
60
2735.03
2990.95
10 %
Coated tablets: Rucaparibum 300 mg
mmpharm GmbH
A / SL
FB
G
L
IP
Rubraca 300 mg
120
5470.06
5920.10
10 %
Coated tablets: Rucaparibum 300 mg
mmpharm GmbH
A / SL
FB
G
Topotecan (L01XX17) 5 products
WHO-DDD
DrugBank.ca
L
IP
Hycamtin 1 mg
Durchstechflasche(n)
75.72
98.30
10 %
Lyophilisate: Topotecanum 1 mg
Sandoz
Pharmaceuticals AG
A / SL / SO
FB
G
L
IP
Hycamtin 4 mg
Durchstechflasche(n)
269.88
308.25
10 %
Lyophilisate: Topotecanum 4 mg
Sandoz
Pharmaceuticals AG
A / SL / SO
FB
G
L
IP
Hycamtin 4 mg
5 Durchstechflasche(n)
1343.74
1469.55
10 %
Lyophilisate: Topotecanum 4 mg
Sandoz
Pharmaceuticals AG
A / SL / SO
FB
G
L
IP
CI
Hycamtin 0.25 mg
10 Capsule(s)
137.40
165.85
10 %
Capsules: Topotecanum
Sandoz
Pharmaceuticals AG
A / SL
FB
G
L
IP
CI
Hycamtin 1 mg
10 Capsule(s)
549.59
614.15
10 %
Capsules: Topotecanum 1 mg
Sandoz
Pharmaceuticals AG
A / SL
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
